NOX
ASX:NOX
Noxopharm Limited
- Stock
locale
Australia
market
STOCKSindustry
Biotechnologywebsite
www.noxopharm.comipo date
Aug 09, 2016
Noxopharm Limited, a drug development company, focuses on developing treatment options for a range of solid tumor cancers and septic shock in Australia and internationally. It primarily develops Veyonda, which is an adjuvant therapy in chemotherapy and radiotherapy for the treatment of late-stage cancers. The company also develops DARRT program that is in Phase 1b/2a for the tr...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus